C. W. Francis

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

C. W. Francis, Craig M. Kessler, Samuel Z. Goldhaber et al. · Journal of Thrombosis and Haemostasis · 2015 · 241 citations · Full text

Medicine, Oncology, Pharmacology +16

Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor‐2 (FGF‐2)

Abha Sahni, P. J. Simpson‐Haidaris, Sangita Sahni et al. · Journal of Thrombosis and Haemostasis · 2008 · 238 citations

Life Sciences, Cell Biology, Oncology +11

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study

Clifford W. Colwell, Scott D. Berkowitz, Bruce L. Davidson et al. · Journal of Thrombosis and Haemostasis · 2003 · 142 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: A pooled analysis of three trials

Richard J. Friedman, O.E. Dahl, Nadia Rosencher et al. · Thrombosis Research · 2010 · 141 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Magnetic relaxation in blood and blood clots

Robert G. Bryant, Keith A. Marill, C. Craig Blackmore et al. · Magnetic Resonance in Medicine · 1990 · 135 citations

Natural Sciences, Biophysics, Physics +15